A 40-year-old woman presents with polyarthralgia, morning stiffness >1 hour, and symmetrical swelling of MCP and PIP joints. ESR and CRP are elevated, and rheumatoid factor and anti-CCP antibodies are positive. According to Canadian rheumatology guidelines, what is the initial disease-modifying pharmacotherapy of choice?